Maliki to Asharq Al-Awsat: There is No Alternative But to Win The Jerusalem Battle

Palestinian Foreign Minister Riyad Al-Malki (left) with his Italian counterpart in Rome on Thursday as part of his European tour (EPA).
Palestinian Foreign Minister Riyad Al-Malki (left) with his Italian counterpart in Rome on Thursday as part of his European tour (EPA).
TT

Maliki to Asharq Al-Awsat: There is No Alternative But to Win The Jerusalem Battle

Palestinian Foreign Minister Riyad Al-Malki (left) with his Italian counterpart in Rome on Thursday as part of his European tour (EPA).
Palestinian Foreign Minister Riyad Al-Malki (left) with his Italian counterpart in Rome on Thursday as part of his European tour (EPA).

Palestinian Foreign Minister Riyad Al-Maliki expressed his confidence in the ability of the Palestinians to overcome the existing disputes over postponing the legislative elections.

In an interview with Asharq Al-Awsat, Maliki noted that this issue has “hastened the launch of the battle of Jerusalem,” emphasizing its “priority with regard to all Palestinian factions.”

The minister, who visited Moscow as part of a European tour, pointed to Palestinian President Mahmoud Abbas’ proposal to form a government of national unity, saying: “All factions agree that Jerusalem is a red line... But it is important to deal with the situation in good faith and work to unify the Palestinian house in the West Bank and the Gaza Strip and to protect Jerusalem, where Israel exploits our division to escalate its violations.”

Maliki continued: “We can overcome all the existing problems by forming a government of national unity. Not all factions… will converge on the same position, and some may go far to exploit the situation to question the leadership and its legitimacy. There are other parties, such as Hamas, which proved their eagerness to end the division during the Istanbul and Cairo meetings.”

While the Palestinian foreign minister emphasized the willingness of Fatah and Hamas to work towards unity, he noted that the two sides did not have enough time to expand the understandings.

“They preferred to go towards the shortest path, which is holding the elections, before completing the adequate preparations. Here, many pitfalls emerged, especially the issue of Jerusalem,” Maliki told Asharq Al-Awsat.

Asked about his European tour and Moscow discussions, the Palestinian foreign minister said that a number of issues were on the agenda, underlining the importance of communication with Russia, especially with regards to Israel’s violations.

“We are counting on Moscow to pressure the Israeli side to stop these ongoing violations, as well as to compel Tel Aviv to abide by the signed agreements that guarantee the holding of Palestinian elections on all territories, including those under Area C, which comprise Jerusalem,” Maliki said.

He continued: “We also rely on a Russian role to influence Israel in the course of advancing the political process, and we support the Russian efforts within the framework of reviving the work of the International Quartet and the invitation made by Minister Sergei Lavrov to hold a meeting of the international group at the ministerial level.”

On whether he was optimistic about efforts to revive the international quartet, Maliki noted a change in the US position after US President Joe Biden assumed office. He said that the quartet held two meetings at the delegates’ level, including one upon an American request.

“Now Lavrov is talking about calling for a meeting at the ministerial level, and this is important. Maturing ideas and restoring confidence between the parties is required. For us, there is no alternative to this framework, because it is the official context adopted within UN Security Council Resolution 1515,” the minister remarked.

Asked whether there was a clear Palestinian plan to pressure Israel at the international level, Maliki said: “The moment the international community is able to oblige Israel to implement its pledges, we will move immediately to set a new date for the elections.”

“We are not trying to evade the elections. In fact, it was President Abbas who launched the idea before the United Nations General Assembly in 2017… At the same time, we have a second option to adress the situation, which President Abbas expressed by calling for the formation of a national unity government based on the principles of the Palestinian Liberation Organization,” he stated.

Maliki explained that the proposed national unity government would work on two tracks. First, strengthening the Palestinian movement and ensuring the mobilization of a supportive international position to escalate pressure on Israel on elections, and second, working to dismantle the foundations of the Palestinian division, its institutions, and its elements.

“Such a national framework will have the ingredients for success in both tracks,” he emphasized.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.